NCT00254605Recruiting
Retinal Imaging in Patients With Inherited Retinal Degenerations
High Resolution Retinal Imaging in Patients With Inherited Retinal Degenerations
Source: ClinicalTrials.gov · Last updated 5 Jun 2026
Brief summary (registry, in English)
The purpose of this study is to determine whether the structure and function of the human retina can be studied with high resolution in patients with inherited retinal degenerations using the Adaptive Optics Scanning Laser Ophthalmoscope (AOSLO).
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 14 Nov 2005
- Start date
- 1 Nov 2005
- Primary completion date
- 1 Oct 2028
- Lead sponsor
- University of California, San Francisco
- Diseases
- Retinitis pigmentosa
- NCT number
- NCT00254605
What you commit to
- Study type: Observational
- Planned participants: 400
- From 1 Nov 2005 to the primary completion date, 1 Oct 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior refractive surgery
Other
- Cataract
- Irregular corneal astigmatism (keratoconus)
Who the study is looking for
- Subjects must speak and understand English
- Subjects must have pupils that dilate to at least 6 millimeters diameter.
- Subjects must be willing to travel to University of California (UC) Berkeley.
- Subjects are financially responsible for their travel to the San Francisco area if they are not San Francisco residents.
Age in the registry: 13 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Ophthalmology Retinal Degenerations Clinic, UCSF Coordinator of this site? Confirm its status | San Francisco | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.